|
2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- Suppliers list
|
|
| | 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- Basic information |
| Product Name: | 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- | | Synonyms: | 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)-;(2R,5S,13aR)-N-(2,4-Difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide;Chlorfenvinphos Impurity 9;Bikagwe Impurity 4 | | CAS: | 1611493-56-1 | | MF: | C21H19F2N3O5 | | MW: | 431.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1611493-56-1.mol | ![2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- Structure](CAS/20210305/GIF/1611493-56-1.gif) |
| | 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- Chemical Properties |
| Boiling point | 695.2±55.0 °C(Predicted) | | density | 1.58±0.1 g/cm3(Predicted) | | pka | 4.50±1.00(Predicted) |
| | 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- Usage And Synthesis |
| | 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-, (2R,5S,13aR)- Preparation Products And Raw materials |
|